[go: up one dir, main page]

IL171636A - Pharmaceutical compositions containing a plasminogen activating factor for use in the treatment of stroke - Google Patents

Pharmaceutical compositions containing a plasminogen activating factor for use in the treatment of stroke

Info

Publication number
IL171636A
IL171636A IL171636A IL17163605A IL171636A IL 171636 A IL171636 A IL 171636A IL 171636 A IL171636 A IL 171636A IL 17163605 A IL17163605 A IL 17163605A IL 171636 A IL171636 A IL 171636A
Authority
IL
Israel
Prior art keywords
stroke
treatment
pharmaceutical compositions
compositions containing
activating factor
Prior art date
Application number
IL171636A
Other languages
Hebrew (he)
Original Assignee
Lundbeck & Co As H
Paion Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2004/004626 external-priority patent/WO2004096268A2/en
Application filed by Lundbeck & Co As H, Paion Deutschland Gmbh filed Critical Lundbeck & Co As H
Publication of IL171636A publication Critical patent/IL171636A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49Urokinase; Tissue plasminogen activator
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • A61K38/58Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL171636A 2003-05-02 2005-10-27 Pharmaceutical compositions containing a plasminogen activating factor for use in the treatment of stroke IL171636A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EPPCT/EP2003/004608 2003-05-02
PCT/EP2003/004729 WO2004096267A1 (en) 2003-05-02 2003-05-06 Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke
PCT/EP2004/004626 WO2004096268A2 (en) 2003-05-02 2004-04-30 Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke

Publications (1)

Publication Number Publication Date
IL171636A true IL171636A (en) 2013-07-31

Family

ID=33395696

Family Applications (1)

Application Number Title Priority Date Filing Date
IL171636A IL171636A (en) 2003-05-02 2005-10-27 Pharmaceutical compositions containing a plasminogen activating factor for use in the treatment of stroke

Country Status (13)

Country Link
JP (1) JP2012077090A (en)
CN (1) CN1849133B (en)
AU (3) AU2003227721A1 (en)
CY (1) CY1114254T1 (en)
DK (1) DK1622639T3 (en)
EA (2) EA013837B1 (en)
ES (1) ES2401782T3 (en)
IL (1) IL171636A (en)
MY (1) MY151447A (en)
PT (1) PT1622639E (en)
SI (1) SI1622639T1 (en)
WO (1) WO2004096267A1 (en)
ZA (2) ZA200509053B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10153601A1 (en) 2001-11-02 2003-05-22 Paion Gmbh DSPA for the treatment of stroke
TWI445540B (en) 2007-04-20 2014-07-21 Ajinomoto Kk Anti-hypothermia composition
EP2014296A1 (en) * 2007-07-10 2009-01-14 PAION Deutschland GmbH Novel strategies for increasing the reperfusion in obstructed blood vessel
AR067345A1 (en) * 2007-07-10 2009-10-07 Paion Deutschland Gmbh USE OF THROMBOMODULIN FOR THE PREPARATION OF A THROMBOLITIC MEDICINAL PRODUCT

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69054B1 (en) * 1988-07-20 1996-08-07 Schering Ag Vampire bat salivary plasminogen activators
NL8902454A (en) * 1989-10-03 1991-05-01 Stichting Centraal Lab MUTANTS OF THE HUMANE PLASMINOGENIC ACTIVATOR INHIBITOR 1 (PAI-1), THEIR PREPARATION AND USE, AND RECOMBINANT POLYNUCLEOTIDES INCLUDING GENETIC INFORMATION CODING FOR THESE MUTANTS.
WO1993005150A1 (en) * 1991-09-05 1993-03-18 Schering Aktiengesellschaft Collagen-induced platelet aggregation inhibitor
DE10153601A1 (en) * 2001-11-02 2003-05-22 Paion Gmbh DSPA for the treatment of stroke

Also Published As

Publication number Publication date
HK1092045A1 (en) 2007-02-02
CN1849133A (en) 2006-10-18
DK1622639T3 (en) 2013-04-15
AU2004233601B2 (en) 2009-11-26
AU2004233601A1 (en) 2004-11-11
ZA200703704B (en) 2008-08-27
ES2401782T3 (en) 2013-04-24
JP2012077090A (en) 2012-04-19
CN1849133B (en) 2011-03-30
MY151447A (en) 2014-05-30
AU2003227721A1 (en) 2004-11-23
EA013837B1 (en) 2010-08-30
EA200501733A1 (en) 2006-06-30
SI1622639T1 (en) 2013-05-31
WO2004096267A1 (en) 2004-11-11
CY1114254T1 (en) 2016-08-31
PT1622639E (en) 2013-04-01
EA201000501A1 (en) 2010-10-29
AU2010200718A1 (en) 2010-03-18
ZA200509053B (en) 2007-11-28

Similar Documents

Publication Publication Date Title
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
GB2394894B (en) New use for pharmaceutical composition
ZA200506941B (en) Improvements in or relating to drive mechanisms suitable for use in drug delivery devices
IL170758A0 (en) 7-amino-isoindolyl compounds and their pharmaceutical uses
GB0324761D0 (en) Use of compounds in therapy
IL176248A0 (en) N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
EP1682136A4 (en) Therapeutic compounds and uses thereof
GB0300427D0 (en) Pharmaceutical composition
GB0307866D0 (en) Pharmaceutical composition
EP1699458A4 (en) Pharmaceutical composition
GB0316206D0 (en) Pharmaceutical formulation
IL183893A0 (en) Pharmaceutical compositions for the treatment of cellulite
PT2340872T (en) New pharmaceutical formulations useful in the treatment of insomnia
EP1600445A4 (en) Medicinal composition
IL171636A (en) Pharmaceutical compositions containing a plasminogen activating factor for use in the treatment of stroke
GB0300885D0 (en) Pharmaceutical composition
PL361364A1 (en) Peptide and pharmaceutical composition as well as their therapeutic applications
GB0306933D0 (en) Pharmaceutical composition
AU2003215767A8 (en) Devices for use in medicine
GB0312844D0 (en) Use of compounds in medicine
GB0307869D0 (en) Pharmaceutical composition
ZA200603126B (en) Pharmaceutical compositions for therapeutic use
GB0307864D0 (en) Pharmaceutical composition
GB0307867D0 (en) Pharmaceutical composition
GB0307862D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees